Survodutide
A Study in Women With Overweight or Obesity to Test Whether Different Doses of BI 456906 Influence the Amount of a Contraceptive in the Blood
Boehringer Ingelheim · Phase 1 · Completed · Enrollment 32
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Microgynon® (Reference treatment (R)) followed by BI 456906 and Microgynon® (Test treatment (T)) | n/r | n/r | n/r | n/r |
Not shown
- Microgynon® (Reference treatment (R)) followed by BI 456906 and Microgynon® (Test treatment (T)): endpoint not reported